GEODE CAPITAL MANAGEMENT, LLC

Position in TENX — Tenax Therapeutics, Inc.

CIK 1214717 BOSTON, MA

Position in TENX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$9,305,263

+$8,199,396 QoQ

Shares Held

639,537

+824.7% QoQ

Ownership

1.71%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#12

of 111 holders

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. TENX ranks #195 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,017,848	$2,989,245,636
2	REGN	Regeneron Pharmaceuticals, Inc.	2,625,810	$1,637,297,566
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,635,840	$793,466,914
4	RVMD	Revolution Medicines, Inc.	3,942,676	$738,384,360
5	MRNA	Moderna, Inc.	9,710,335	$680,014,759
6	INCY	Incyte Corp	4,750,735	$538,543,319
7	RPRX	Royalty Pharma plc	8,058,048	$451,814,751
8	INSM	INSMED Inc	4,220,155	$449,952,925

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,305,263	639,537	+824.7%	Shares	Defined	2026-08-12
2026-03-31	$1,105,867	69,160	+24.2%	Shares	Defined	2026-05-15
2025-12-31	$678,970	55,699	+61.8%	Shares	Defined	2026-02-09
2025-09-30	$261,974	34,425	+0.6%	Shares	Defined	2025-11-12
2025-06-30	$197,198	34,236	+2.7%	Shares	Defined	2025-08-08
2025-03-31	$218,383	33,341	+36.9%	Shares	Defined	2025-05-13
2024-12-31	$150,751	24,354	+32.4%	Shares	Defined	2025-02-12
2024-09-30	$63,628	18,390	+66.6%	Shares	Defined	2024-11-12
2024-06-30	$33,288	11,041	-92.5%	Shares	Defined	2024-08-09
2023-12-31	$40,732	148,118	+24.5%	Shares	Defined	2024-02-13
2023-09-30	$35,574	118,978	—	Shares	Defined	2023-11-13
No filing history on record for this holder in this stock.